William Haskel, CLO, General Counsel & Sec. at Paratek Pharmaceuticals, holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds 0.00 shares in Cambrex (Ticker: CBM).

See the Hottest Stocks Based on Insider Trading >

William Haskel
Paratek Pharmaceuticals (PRTK)
CLO, General Counsel & Sec.

Ranked #94,939 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 8 Profitable Transactions

Average Return

-59.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

William Haskel does not currently own shares as a corporate insider.

A breakdown of William Haskel's holdings

See the Top Stocks by Insiders

Insider Roles

William Haskel does not currently hold a role as a corporate insider.

Roles that William Haskel holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Paratek Pharmaceuticals
(PRTK)

Rating:Informative Sell

Date:Dec 14, 2018 - Dec 14, 2019

Return:+45.50%

The most profitable trade made by William Haskel

See the Latest Stocks Traded by Insiders

William Haskel's Trading History

PRTK

Paratek Pharmaceuticals

Sep 21, 2023

―

Uninformative Sell

―

$0.00

CBM

Cambrex

Nov 17, 2014

―

Informative Sell

179.96K

$0.00

List of latest transactions for each holding click on a transaction to see William Haskel's performance on stock

See All Insider Trading from Today

William Haskel insider profile FAQ

What is the percentage of profitable transactions made by William Haskel?

The percentage of profitable transactions made by William Haskel is 13%.

What is the average return per transaction made by William Haskel?

The average return per transaction made by William Haskel is -59.50%.

What stocks does William Haskel hold?

William Haskel holds: PRTK, CBM stocks.

What was William Haskel’s latest transaction?

William Haskel latest transaction was an Uninformative Sell of ―.

What was William Haskel's most profitable transaction?

William Haskel’s most profitable transaction was an Informative Sell of PRTK stock on December 14, 2018. The return on the trade was 45.50%.

What is William Haskel's role in Paratek Pharmaceuticals?

William Haskel's role in Paratek Pharmaceuticals is CLO, General Counsel & Sec..

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

William Haskel Insider Profile

William Haskel Paratek Pharmaceuticals (PRTK)CLO, General Counsel & Sec.